Disclosure Obligations

Multiple Firms Seek Lead Role in Securities Suit Against ADMA Biologics

The August 10 lead‑plaintiff deadline will decide who directs discovery and strategy in claims alleging undisclosed related‑party sales, channel stuffing, and weak internal controls.